Get started

Health

CVS | FINALLY Time to Enter | LONGCVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
NYSE:CVSLong
by DivergenceSeeker
2
Are Health Savings Accounts Worth Your Time? Absolutely.When you're well, sometimes it is difficult to imagine things suddenly taking a turn for the worse. 1.5 years ago, I was as healthy as could be. I thought medical problems were for other people, my checkups always came up roses. Then I fell ill with an autoimmune neurologic condition, likely autoimmune encephalitis, and I wish I had opened a Health Saving's Account (HSA) the day I turned 18. Funny how life teaches you those lessons. So what is an HSA? An HSA is an investment account whose contributions are tax-deductible and withdrawals are tax-free if used for medical expenses. This type of account is only available for those with high-deductible plans health plans. The IRS defines a high deductible health plan as: any plan with a deductible of at least $1,400 for an individual or $2,800 for a family. Literally ripped that last sentence straight out of google. Sue me. If you're uninsured, you're out of luck. So for those who have high-deductible health plans, it's a way to not only save for sudden health catastrophes, but also to grow your wealth. With Fidelity, there is no limit to what asset class you can partake in. Other HSA's may have limitations, acting more like savings accounts. When you make a contribution, that money is tax-deductible (so you're investing with "pre-tax dollars"), and will never, ever be taxed if used to pay for a medical expense. But what if your investments have gone down and you have to sell to pay for medical bills? Hint: don't. You can reimburse your own medical bills with NO time limit. That means you could pay $1,000 for surgery using a cash-back credit card (or whatever payment method), wait until your money grows in your HSA, then reimburse yourself tax-free in 30 years. That is, if you kept the receipt ;) By budgeting, like using YNAB, it's easy to keep track of medical expenses and reimburse yourself tax-free when it makes the most sense. Or, if you prefer, you can invest in more conservative instruments. Like CD's, which are paying as high as 4.7%. Or you can treat it like an actual savings account and enjoy Fidelity's 2.21% APY on uninvested cash. So for those keeping score: -Contributions are tax deductible -Medical expenses are tax-free when you liquidate your investment(s) to cover them, which you can do retroactively with no time limit -Growth and trading within the account is tax-free (unless you live in CALIFORNIA or NEW JERSEY. Don't ask me, but you will be taxed on trading like you would an individual brokerage account) -You can withdraw your funds like you would an individual brokerage account at 65 (that is, you'll be taxed but not penalized) There are pretty hefty penalties for non-medical withdrawals before you're 65: up to a 20% penalty and ordinary income tax on capital gains. Not pretty, so don't put money into an HSA that you'll need for other things. In addition, there are yearly limits to how much can contribute. For 2023, it's $3,850 for an individual plan, $7,750 for family plans. You can alternatively roll funds over from an IRA into an HSA (but not the other way around). I opened one today with Fidelity and will max it out every year. I use YNAB to budget, so I can keep track of my health expenses for 2023 easy peasy. It's always best to plan for the worst. Thanks for reading, and best of health to you. InTheMoney
NASDAQ:QQQEducation
by InTheMoneyAdam
UnitedHealthGroup Analysis 19.11.2022Welcome to the BasicTrading channel. My name is Philip and in todays analysis I quickly go over the situation which we currently have on UnitedHealth Group. I will analyse the asset both from a weekly and daily timeframe to show you the best possible trading opportunities. If you enjoyed this analysis, let me know in the comment section which asset I should analyse tomorrow. I will personally reply to every single comment. Dont forget to smash that rocket and I will see you tomorrow with a new analysis.
NYSE:UNH
by basictradingtv
3
$XLV:$KRE: Deflation winners and losersWe're seeing value health care ($XLV) show a lot of relative strength against other sectors as the dollar has been pushing. ($KRE) is often tied to growth when compared to it's bigger brother ($XLF) and eventhough financials do tend to benefit from rising rates, this has been much more of a hard landing and the financial rotation many expect may not come to pass, instead look for $XLV to continue soaking up 2022 when compared to other sectors.
AMEX:XLVLong
by Fox_Technicals
HCAT LongTechnical Analysis : We broke the downtrend line and had three white soldiers to confirm the reversal of the trend, also the falling wedge shows a bullish reversal since we broke it upwards. Although on a lower timeframe MACD and RSI look bearish, we expect the price to reach our Buy Zone before the impulsive move upwards. Aroon : Aroon Up on Top and Aroon Down on bottom show a bullish momentum. MACD : We had lower lows on the chart but not on MACD which shows MACD divergence and signals for a reverse of the downtrend. Entry : 21.5-23.5 Target : 39.75 (at Fib50% and just below a previous high and resistance ) Invalidation : 19.5 ( Just Below our support and last low )
NASDAQ:HCATLong
by vf_investment
$MIRM sniper edition #2*This is not financial advice, so trade at your own risks* *My team digs deep and finds stocks that are expected to perform well based off multiple confluences* *Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management* Recap: My team entered $MIRM on October 29, 2021 at $15.70 per share. Our first take profit is at $21. My team averaged down on our position today at $13.57 per share bringing our share average to $14.63 per share. Our First Entry: $15.70 Our 2nd Entry: $13.57 First Take Profit: $21 2nd Take Profit: $26 If you want to see more, please like and follow us @SimplyShowMeTheMoney
NASDAQ:MIRMLong
by SimplyShowMeTheMoney
long $CMPSLooks like the MACD is still heading down but curling up. RSI is bottoming out as it reaches an important level of support. I think the risk reward at the $28 level is optimal. If you have a high risk tolerance, buy now. Shrooms are already decriminalized in Denver and are about to be in Detroit. The TAM which was initially an imaginative number is now becoming real for Compass Pathways. Go long CMPS www.freep.com Looks ready to find a floor and launch on the weekly chart.
NASDAQ:CMPSLong
by EBITDAtiger
2
$MRK: Vaccine KrptoniteInvestors should continue to watch Merck and how it plays out here at the 80 level as their COVID drug treatment is pending approval. I believe the market is absolutely sleeping on the significance of this drug and the kind of impact it will have. A treatment is an absolute game changer provided the politics of COVID do not disrupt innovation, transparency and competition in the market. If Merck's drug is effective at treating COVID this will be disastrous to companies like MRNA, JNJ, DVAX, PFE and NVAX. Currently, we're still sitting at less than a 60% fully vaccinated population, the tightest labor supply in history and a work force petitioning vaccine mandates as was witnessed with Boeing workers in Seattle. This will force lawmakers hands to suspend vaccine mandates indefinitely crashing demand for vaccines in the future. The US population has made their stance and vaccine persuasion will only have a diminishing effect from here on out, so the only option is the option that works for everyone in order to minimize division in the country.
NYSE:MRKLong
by Fox_Technicals
$MIRM doubling down*This is not financial advice, so trade at your own risks* *My team digs deep and finds stocks that are expected to perform well based off multiple confluences* *Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management* Recap: My team entered $MIRM on 5/28/21 at $16.30 per share. Today we're taking the dip opportunity and doubling down at $15.60 per share. FIRST ENTRY: $16.30 2ND ENTRY: $15.60 TAKE PROFIT 1: $20 TAKE PROFIT 2: $30 STOP LOSS: $14.90 If you want to see more, please like and follow us @SimplyShowMeTheMoney
NASDAQ:MIRMLong
by SimplyShowMeTheMoney